Clinical TrialsSearch results
Number of results: 818
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- The long-term clinical study to evaluate the safety of the regenerative medicine and the gene therapy by the autologous transplantation of human LCAT gene transduced human pre-adipocyte
- Familial LCAT deficiency
- Yokote Kotoro
- 2024-10-03
Recruiting
- A Randomized Phase II Clinical Trial Evaluating the Safety and Efficacy of Initial Dose Adjustment of Zolbetuximab Plus Chemotherapy in Patients with HER2-negative and CLDN18.2-positive Unresectable Advanced or Recurrent Gastric, Gastroesophageal junction cancer or esophageal adenocarcinoma
- Gastric cancer
- Nakayama Izuma
- 2024-09-20
Not yet recruiting
- Investigation of the effect of air purifiers with TPA filters on allergens in house dust
- mite allergy disease
- Yamaide Fumiya
- 2024-09-10
Not yet recruiting
- A study to find a suitable dose of BI 765883 and to test whether it helps people with advanced pancreatic cancer when taken alone or together with chemotherapy
- metastatic pancreatic ductal adenocarcinoma
- Nakahara Asuka
- 2024-08-30
Not yet recruiting
- A Phase Ib/II Clinical Trial Evaluating the Safety and Efficacy of Atezolizumab Plus Bevacizumab Combination Therapy as Adjuvant Treatment After Carbon Ion Radiotherapy for Hepatocellular Carcinoma
- hepatocellular carcinoma
- Ogasawara Sadahisa
- 2024-08-20
Not yet recruiting
- Super Lizer in AV fistula creation
- End-stage kidney disease; hemodialysis
- Sugiyama Daisuke
- 2024-08-06
Not yet recruiting
- Super Lizer in venous access
- Breast surgery
- Sugiyama Daisuke
- 2024-08-02
Recruiting
- The simplicity of the single-puncture Clavipectoral fascia plane block
- clavicle fracture
- Tsuge Masatsugu
- 2024-07-31
Recruiting
- Substudy of MK-5684-based Investigational Treatments in mCRPC
- Metastatic Castration resistant Prostate Cancer (mCRPC)
- Tanaka Yoshiyuki
- 2024-07-20
Not yet recruiting
- Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- advanced or metastatic HER2-positive biliary tract cancer
- Oki Kosuke
- 2024-07-19